PharmAthene pharmathene.com

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical threats. PharmAthene's current biodefense portfolio includes the following product candidates: SparVax - a next generation recombinant protective antigen (rPA) anthrax vaccine; Recombinant BChE - a bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents; an...Show all

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical threats. PharmAthene's current biodefense portfolio includes the following...Show all

See All Exits Recent Exits

Phone: 410-269-2600

Fax:

One Park Place
Suite 450
Annapolis, 21401
Maryland, United States

PharmAthene - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2017-01-19AltimmuneReverse Merger
See all 1 investments